1 |
Salvi GE, Yalda B, Collins JG. Inflammatory Mediator Response as a Potential Risk Marker for Periodontal Diseases in Insulin-Dependent Diabetes mellitus patients. J Periodontol 1997;68:127-135
DOI
PUBMED
ScienceOn
|
2 |
Bissada NF, Manoucher-Pour M, Haddow M and Spagnulo PJ. Neutrophil functional activity in juvenile and adult onset diabetic patients with mild and severe periodontitis. J Periodont Res 1982;17:500-502
DOI
|
3 |
Offenbacher S, Heasman PA, Collins JG. Modulation of host secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-444
PUBMED
|
4 |
Chang Y-C, Yang S-F, Lai C-C, Liu J-Y and Hsieh Y-S. Regulation of matrix metalloproteinase production by cytokines, pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures. J Periodont Res 2002; 37:196-203
DOI
ScienceOn
|
5 |
Offenbacher S, Odle BM, Van Dyke TE. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986;21:101-112
DOI
|
6 |
Socransky SS, Haffajee AD, Goodson JM, Lindhe J. New concepts of destructive periodontal disease. J Clin Periodontol 1984;11:21-32
DOI
|
7 |
Trengove NJ. Stacey MC. MacAuley S et al. Analysis of the acute and chronic wound environments: the role of proteases and the inhibitors. Wound Repair Regeneration 1999;7:442-52
DOI
ScienceOn
|
8 |
Ryan ME, Ramamurthy NS, Sorsa T, Golub LM. MMP-mediated events in diabetes. Ann NY Acad Sci 1999;873:311-314
|
9 |
Erwin van der Zee, Everts V and Beertsen W. Cytokines modulate routes of collagen breakdown. J Clin Periodontol 1997;24:297-305
DOI
ScienceOn
|
10 |
Emrich LJ, Shlosman M and Genco RJ. Periodontal disease in non-insulin dependent diabetes mellitus. J Periodontol 1991; 62:123-129
DOI
PUBMED
|
11 |
H. Sato, T. Takino, Y. Okada et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells, Nature 1994;370:61-65
DOI
ScienceOn
|
12 |
R. Achong, I Nishimura, H. Ramachandran et al. Membrane Type(MT)1-matrix metalloproteinase( MMP) and MMP-2 expression in ligature-induced periodontitis in the rat. J Periodontol 2003;74:494-500
DOI
|
13 |
Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274: 21491-21494
DOI
|
14 |
Hayakawa H, Yamashita K, Ohwaki K. Collagenase activity and tissue inhibitor of metalloproteinases-1(TIMP-1)content in human whole saliva from clinically healthy and periodontally diseased subjects, J Periodont Res 1994;29:305-308
DOI
|
15 |
Golub LM, Lee HM, Lehrer G. Minocycline reduces gingivalcollagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodont Res 1983;18:516-526
DOI
|
16 |
Ohuchi E, Imai K, Fujii Y et al. Membrane type-1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272:24413-2451
|
17 |
Drouin L, Overall CM, Sodea J. Identification of matrix metalloproteinase inhibitor (TIMP) in human parotid saliva : partial purification and characterization. J Periodont Res 1988;23:370-377
DOI
|
18 |
Choi DH, Moon IS, Choi BK et al. Effects of sub-antimic robial dose doxycycline therapy on crevicular fluid MMP-8 and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis. J Periodont Res 2004;39:20-26
DOI
ScienceOn
|
19 |
Mundy, GR. Inflammatory mediators and the destruction of bone. J Periodont Res 1991;26:213-217
DOI
|
20 |
Collin H-L, Uusitupa M and Niskanen L. Periodontal findings in elderly patient with non-insulin depedent diabetes mellitus. J Periodontol 1998;69:962-966
DOI
PUBMED
ScienceOn
|
21 |
Page RC and Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 1976;34:235-249
PUBMED
|
22 |
Kang MG, Cha HG, Song SH et al. MMP-2, MMP-8 Expression in gingival tissue of chronic periodontitis associated to Type 2 Diabetes Mellitus. Journal of Korean Academy of Periodontology 2005;35:661-674
|
23 |
O'Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 1993;330:156-160
PUBMED
|
24 |
Kuauper V, Will H, Lopez-Otin C et al. Cellular mechanisms, for human procollagenase-3 (MMP-13) activation. Evidence that MTI-MMP (MMP-14) and gelatinase A(MMP-2) are able to generate active enzyme. J Biol Chem 1996;271:17124-17131
DOI
ScienceOn
|
25 |
Ryan EM and Golub LM. Modulation of Matrix metalloproteinase activities in periodontitis as a treatment strategy. Periodontology 2000 2000;24:226-238
DOI
|
26 |
Taylor GW, Burt BA, Becker MP et al. Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol 1998;69:76-83
DOI
PUBMED
ScienceOn
|
27 |
Uitto VJ, Overall CM and McCulloch C. Proteolytic host cell enzymes in gingival crevice fluid. Periodentology 2000 2003;31: 77-104
DOI
ScienceOn
|
28 |
Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993;28:500-510
DOI
ScienceOn
|
29 |
Matejka M, Ulm C, Nell A et al. Stimulation of PGI2 synthesis in the periodontal tissue by interleukin -1 and -1 Adv Exp Med Biol 1997;433:443-446
PUBMED
|
30 |
Noguchi K, Shitashige M, Ishikawa I. Involvement of cyclooxygenase-2 in interleukin la -induced prostaglandin production by human periodontal ligament cells. J Periodontol 1999;70:902-908
DOI
|
31 |
Birkendal-Hansen H. Role of Matrix Metalloproteinases In Human Periodontal Diseases. J Periodontol 1993;64:474-484
PUBMED
|
32 |
Cho JY, Xing S, Liu X et al. Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene delivary. Gene Therapy 2000;7:740-749
PUBMED
|
33 |
AAP Position Paper. Diabetes and peridontal disease. J Periodontol 1999;70:935-949
DOI
|
34 |
Zhong Y, Slade GD, Beck JD, Offenbacher S. Gingival crevicular fluid interleukin-1beta, prostaglandin E2 and periodontal status in a community population. J Clin Periodontol 2007;34(4) :285-93
DOI
ScienceOn
|
35 |
M. Seiki. The cell surface: the stage for matrix metalloproteinase regulation of migration' Curr. Opin. Cell Biol. 2002;14:624-632
DOI
ScienceOn
|